A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers

NCT05928585 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune System Diseases
Autoimmunity

Interventions

DRUG: HIB210
DRUG: Placebo

Sponsor

HI-Bio, A Biogen Company